Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis.
Modulation of tissue resident memory T cells by glucocorticoids after acute cellular rejection in lung transplantation.
Risk of abnormal pregnancy outcome in carriers of balanced reciprocal translocations involving the Miller-Dieker syndrome (MDS) critical region in chromosome 17p13.3.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Res Treat. 2020 Jun; 181(3):623-633.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Biomarkers, Tumor
Breast Neoplasms
Capecitabine
Drug-Related Side Effects and Adverse Reactions
Female
Ferredoxin-NADP Reductase
Follow-Up Studies
Genotype
Germ-Line Mutation
Humans
Methylenetetrahydrofolate Reductase (NADPH2)
Middle Aged
Polymorphism, Single Nucleotide
Prognosis
Prospective Studies
Quality of Life
authors with profiles
Nancy Jean Cox
Philip Hoffman
Gini Fleming
Mark Ratain
Douglas Merkel
Rita Nanda
Olufunmilayo Olopade
Mary Dolan
Dezheng Huo
Olwen Hahn
Peter O'Donnell